BTC-8

CAS No. ——

BTC-8( BTC 8 | BTC8 )

Catalog No. M17097 CAS No. ——

A derivative of BAM-7 that acts as a nove potent, direct activator of Bax with EC50 of 700 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BTC-8
  • Note
    Research use only, not for human use.
  • Brief Description
    A derivative of BAM-7 that acts as a nove potent, direct activator of Bax with EC50 of 700 nM.
  • Description
    A derivative of BAM-7 that acts as a nove potent, direct activator of Bax with EC50 of 700 nM; inhibits GBM cell proliferation, arrests the cell cycle, and induces apoptosis through the induction of mitochondrial membrane permeabilization; also blocks proliferation and self-renewal of GSCs and induces their apoptosis; sensitizes both GBM cells and GSCs to the alkylating agent Temozolomide.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BTC 8 | BTC8
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bcl-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    457.534
  • Molecular Formula
    C26H27N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N(C2=CC=C(C3=CC=C(N(C)C)C=C3)C(O)=C2)N=C(C)/C1=N\NC4=CC=CC=C4OCC
  • Chemical Name
    (E)-2-(4'-(dimethylamino)-2-hydroxy-[1,1'-biphenyl]-4-yl)-4-(2-(2-ethoxyphenyl)hydrazono)-5-methyl-2,4-dihydro-3H-pyrazol-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Daniele S, et al. ACS Chem Neurosci. 2017 Jan 18;8(1):100-114. 2. Stornaiuolo M, et al. J Med Chem. 2015 Mar 12;58(5):2135-48.
molnova catalog
related products
  • ABT-199

    Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays.

  • BI-3812

    A highly potent and efficacious BCL6 inhibitor that potently inhibits the interaction of the BTB/POZ domain of BCL6 with several co-repressors in vitro with IC50 of <3 nM.

  • HA14-1

    HA14-1 a small molecule, nonpeptidic Bcl-2 antagonist that binds Bcl-2 surface pocket with binding IC50 of 9 uM.